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PregnancyAbstract Background: Although the antioxidant property of vitamin C as well as its endothelial
function promotion are well documented, its role in fetal growth during pregnancy is still not
conclusive in previous studies.
Objectives: This study aimed to estimate maternal and cord blood vitamin C level and to detect its
inﬂuence on neonatal growth as well as placental weight and placental apoptosis.
Methods: The study was conducted on 60 healthy singleton pregnant women and their full term
neonates at Ain Shams University Hospital in Egypt. Maternal and cord blood vitamin C plasma
level estimation as well as quantitative analysis of placental apoptotic index were done in addition
to full anthropometric assessment for delivered neonates.
Results: There was a positive signiﬁcant correlation between maternal and neonatal vitamin C
levels (r= 0.838, P< 0.001). Positive signiﬁcant correlations between maternal vitamin C levels
and neonatal weight (r= 0.448 , P< 0.001), length (r= 0.67, P< 0.001), BMI (r= 0.52,
P= 0.003), OFC (r= 0.60, P< 0.001) and placental weight (r= 0.373, P< 0.001) while a
signiﬁcant negative correlation with placental apoptotic index (r= 0.817, P< 0.001) were
detected. Multiple regression analysis showed that placental weight was the most sensitive predictor
of neonatal weight (t= 4.132, P< 0.001) followed by maternal vitamin C (t= 3.034, P= 0.006).
Conclusion: Maternal vitamin C level has a signiﬁcant positive impact on neonatal anthropometry
and placental weight while negatively correlating with placental apoptosis. This denotes an impor-
tant role of vitamin C in fetal and placental growth during pregnancy.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric Association.Introduction
Human fetal growth is characterized by sequential patterns of
tissue and organ growth, differentiation and maturation. In
early gestation, the major determinant of fetal growth is the
Maternal–cord blood vitamin C status 81fetal genome. In late pregnancy; environmental, nutritional,
and hormonal inﬂuences become increasingly important.1
Low birth weight signiﬁcantly contributes to mortality and
morbidity in babies both immediately after birth and during
the early childhood years. Poor maternal nutrition has been
implicated as one of the key ‘‘adverse environmental inﬂuences
in utero,’’ which could lead to compromised placental and fetal
growth and adverse long-term consequences.2
In addition, pregnancy is a state of metabolic challenge.
Even a normal, healthy pregnancy is a state of oxidative stress
compared with non-pregnancy, and is a challenge to be met by
the mother and her developing baby. Due to its high metabolic
rate and level of mitochondrial activity, the placenta is a key
source of this oxidative stress.3
Oxygen free radicals have been implicated in the etiology of
premature delivery, fetal growth restriction, eclampsia, mater-
nal infections and maternal malnutrition. Risk may, however,
depend on the mother’s antioxidant status which potentially
protects the maternal–fetal unit, thus increasing intrauterine
growth and infant weight at birth.4 Accordingly, poor dietary
intake of antioxidant nutrients or low serum level may partic-
ularly play an important role in the pathophysiology of low
birth weight. Therefore, antioxidant vitamins, such as vitamins
C and E, may play a role in fetal growth.5
Vitamin C or ascorbic acid is a hydro-soluble lactone (syn-
thesized from glucose) that is essential to the human body for
several functions. Unlike many other animal species, humans
and primates lack the terminal enzyme in the biosynthetic
pathway for ascorbic acid synthesis, so diet is crucial for its
availability in these organisms.6 Vitamin C counteracts several
hydroxyl radicals and may contribute in protecting the fetus
from oxygen free radical damage. It is worth noting that vita-
min C is involved in the regeneration of oxidized vitamin E.5
Also vitamin C promotes endothelial cell proliferation during
the inﬂammatory condition, inhibits endothelial cell apoptosis
and lipid peroxide formation, and improves endothelial
function.7
The aim of this study was to estimate maternal plasma vita-
min C level & to ﬁnd its relation with cord blood level of vita-
min C in their off springs and to detect its inﬂuence on
placental growth, apoptosis as well as neonatal anthropome-
try; in normal full term uncomplicated deliveries.
Materials and methods
This cross sectional study was conducted on 60 pregnant
women admitted for delivery and their newborns at Maternity
Hospital, Ain Shams University, Cairo, Egypt in the period
between July 2012 and June 2013.
Inclusion criteria:
– All cases were healthy, booked pregnant women with
regular antenatal care.
– Singleton gestation.
– Absence of signiﬁcant adverse obstetric history includ-
ing history of previous abortion, intrauterine fetal
death, unexplained neonatal deaths or previous off-
spring with chromosomal or congenital anomalies.
– Absence of maternal medications except for iron and
folic acid intake, routinely given as per antenatal man-
agement protocol.– Maternal weight, height and calculated body mass index
(BMI), falling between 5th and 95th centiles, on growth
charts.
– Normal antenatal investigations including complete
blood count (Hb%> 12 gm/dl), kidney, liver function
tests and negative serology for Rubella, Toxoplasma
and Cytomegalovirus.
– All tested babies had antenatal normal biophysical pro-
ﬁle and ultrasound serially performed, using MEDI-
SON SONAGE 8800 with trans abdominal 3.5 MHz
probe, indicating fetal well-being and absence of con-
genital anomalies.
Exclusion criteria:
– Any maternal disease that could affect either vitamin C
level or feto-placental growth like preeclampsia, diabe-
tes, kidney, liver, heart disease, sepsis, sickle cell disease
or genital infections.
– Maternal smoking, alcohol or drug abuse.
– Premature deliveries.
Informed consents were obtained from all subjects of the
study. The research followed the tenets of the declaration of
Helsinki and was approved by hospital ethics committee.
All pregnant women were subjected to
– Full history taking laying stress on their antenatal his-
tory, vitamin and mineral supplementation, dietetic his-
tory with 24 h recall of feeding, socio-economic status
using Park and Park score8 and drug history.
– Maternal weight and height measurements with calcula-
tion of their BMI (kg/m2).
– Neonatal examination including Ballard scoring for ges-
tational age assessment9, Apgar scoring10 as well as full
anthropometric measures including weight, length,
occipitofrontal circumference (OFC), left mid arm cir-
cumference (MAC) and abdominal girth. Anthropomet-
ric measures were performed on the same day of delivery
using standardized equipments and were plotted on
growth charts.11 Further, calculation of neonatal BMI
was done.12 Babies were classiﬁed according to percen-
tiles of weight for GA into appropriate for gestational
age (AGA); lies between the 10th and 90th percentiles,
small for gestational age (SGA); <10th percentile and
large for gestational age (LGA); >90th percentile.11
– Weighing the placenta and assay of placental apoptosis
assay.
– Plasma vitamin C assay for both the mother and their
babies.
Sampling procedure
Blood samples were collected from the mothers just before
delivery and from cord blood immediately after delivery in
lithium heparin collecting tubes and centrifuged for 30 min
for plasma separation waiting for vitamin C quantitative anal-
ysis within 24 h of sample collection, using the colorimetric
technique.





BALLARD score (wks.) 38.86(0.86)
Neonatal weight (kg) 3.25(0.68)
Neonatal length (cm) 49.83(2.36)
Neonatal head circumference (cm) 34.88(1.28)
Neonatal BMI (kg/m2) 12.94(1.85)
Neonatal left MAC (cm) 11.71(1.19)
Neonatal Abdominal girth (cm) 31.50(2.98)
Placental weight (gm.) 628.33(77.32)
Cord blood vitamin C (mg/l) 13.05(3.70)
BMI: body mass index, MAC: mid arm circumference.
#: number(%).
82 A.M. Hegazy et al.Principle of vitamin C assay
In serum and plasma, vitamin C is found as ascorbic acid as
well as its oxidized form, dehydro-ascorbate. Both forms are
biologically active. In vitamin C assay, an oxidation is induced
prior to analysis so that both forms are measured. A dose
response curve of the absorbance unit (optical density, OD
at 492 nm) vs. concentration is generated, using the values
obtained from the standard. The concentration of the patient
sample is determined directly from the linear standard curve.
Normal range: 4–15 mg/l.13
Placental apoptosis assay
Placental samples, 2 cm · 2 cm, were collected from the basal
plate of the immediately delivered placentas and samples were
stored in formalin 10% for pathological examination and
quantitative analysis of apoptotic index by determining the
ratio of apoptotic nuclei to the total number of nuclei in ten
high power ﬁelds for assessment of each specimen.14
Statistical analysis
Data were analyzed using Statistical Program for Social Sci-
ence (SPSS) version 18.0. Quantitative data were expressed
as mean ± standard deviation (SD). Qualitative data were
expressed as frequency and percentage (%). One-way analysis
of variance (ANOVA) when comparing between more than
two means. One-Way ANOVA Post Hoc test (Bonferroni) to
determine which means differ. Pearson’s correlation coefﬁcient
(r) test was used for correlating data. Multiple Linear Regres-
sion Analysis by creating a statistical model that shows the
relationship between the dependent variable and the explana-
tory factors. P-value <0.05 was considered signiﬁcant.
Results
Descriptive data of the enrolled mothers and their offspring
are shown in Tables 1 and 2. Forty-two (70%) of babies were
AGA, 8 (13.3%) were LGA while 10 (16.6%) were SGA.
In this work, vitamin C levels in both maternal sera and
cord blood of involved neonates were within normal levels
(The mean value of maternal vitamin C was 7.29 ± 2.56 mg/l
while in cord blood it was 13.05 ± 3.70 mg/l).Table 1 Descriptive data of enrolled mothers.
Parameters Mean (SD)
Maternal age (years) 28.4(4.81)
Maternal weight (kg) 90.6(13.31)
Maternal height (cm) 161.43(2.25)
Maternal BMI (kg/m2) 34.67(5.01)
Weeks of gestation (wks) 39.23(1.33)
Parity 1.43(1.38)
Gravidity 2.73(1.76)
Social status (Park & Park score) 14.03(3.91)
Plasma vitamin C(mg/l) 7.29(2.56)
BMI: body mass index.A positive signiﬁcant correlation between vitamin C levels
of mothers and cord blood vitamin C levels was detected
(Fig. 1). In multiple regression analysis, vitamin C level of
mothers was the most sensitive predictor of vitamin C level
of the neonate (t= 2.866, P= 0.008). Other independent fac-
tors, including placental apoptotic index (t= 0.273,
p= 0.787), placental weight (t= 0.329, p= 0.745), gesta-
tional age (t= 0.091, p= 0.929) and neonatal weight
(t= 1.322, p= 0.198) were not signiﬁcant predictors.
Also, positive signiﬁcant correlations between maternal
vitamin C levels and neonatal weight (r= 0.448 &
p< 0.001) (Fig. 2), length (r= 0.67, P< 0.001), BMI
(r= 0.52, P= 0.003) and OFC (r= 0.60, P< 0.001) as well
as placental weight were detected (r= 0.373 & p< 0.001)
(Fig. 3). Moreover, a negative signiﬁcant correlation was
found between maternal vitamin C level and placental apopto-
tic index (r= 0.817 & p< 0.001) (Fig. 4). Further, placental
apoptotic index had a negative signiﬁcant correlation with
neonatal weight (r= 0.460, P= 0.011), BMI (r= 0.528,
P= 0.003) as well as with placental weight (r= 0.577,
P= 0.001).
On comparing between the three groups of neonates; AGA,
SGA and LGA, we found that maternal weight and BMI were
signiﬁcantly higher among the LGA group compared to AGA
and SGA groups. Also, the LGA group had signiﬁcantly
higher placental weight and lower apoptotic index compared
to both AGA and SGA. Signiﬁcantly higher values of both
maternal and neonatal plasma vitamin C were shown in the
LGA group compared to SGA and in the AGA group com-
pared to SGA (Table 3).
Further, maternal BMI had signiﬁcant positive correlations
with neonatal weight (r= 0.458, P= 0.011) and neonatal
BMI (r= 0.484, P= 0.007) while, maternal age had no signif-
icant correlations with neonatal anthropometry, placental
weight, apoptotic index or vitamin C levels of mothers and
babies.
Multiple regression analysis showed that placental weight
was the most sensitive predictor of neonatal weight
(t= 4.132, P< 0.000) followed by maternal vitamin C (t=
3.034, P= 0.006). Maternal BMI (t= 2.005, P= 0.056), pla-
cental apoptotic index (t= 0.052, p= 0.959) and gestational
age (t= 1.801, P= 0.084) were not signiﬁcant predictors of
neonatal weight.
Figure 1 A scattered graph showing a positive signiﬁcant correlation between neonatal plasma vitamin C levels and maternal plasma
vitamin C levels (r= 0.838 & p< 0.001).
Figure 2 A scattered graph showing a positive signiﬁcant correlation between maternal vitamin C levels and neonatal weight. (r= 0.448
& p< 0.001).
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In the current work, vitamin C level of cord blood was higher
than its level in maternal plasma. This result corroborates with
previous studies that found similar ﬁndings, they explained
their results by that placenta is permeable to dehydroascorbicacid but not to ascorbic acid then the fetus converts dehydro-
ascorbic acid to ascorbic acid and accumulates it.15,16 Also
increased vitamin C levels in cord blood could be due to fetal
synthesis of vitamin as dehydroascorbic acid, the oxidized
form of ascorbic acid, that is reduced to L-ascorbic acid by
fetal erythrocytes that gets trapped in the fetal circulation.17
Figure 3 A scattered graph showing a positive signiﬁcant correlation between maternal vitamin C levels and placental weight. (r= 0.373
& p< 0.001).
Figure 4 A scattered graph showing a negative signiﬁcant correlation between maternal vitamin C levels and placental apoptotic index
(r= 0.817 & p< 0.001).
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min C levels of mothers and cord blood vitamin C levels was
detected. In addition, vitamin C level of mothers was the most
sensitive predictor of vitamin C level of the neonate by multi-
ple regression analysis. These results were consistent with a
previous study that suggested that maternal vitamin C intake
can inﬂuence fetal vitamin C levels.17In this work, forty-two (70%) of babies were AGA, 8
(13.3%) were LGA while 10 (16.6%) were SGA. Though the
normal population distribution is 10% SGA, 80% AGA and
10% LGA11 the higher SGA proportion in our study may be
attributed to small sample size and difference in ethnic popu-
lation also, it may be explained by other studies that reported
approximately 10 percent of term infants in developed
Table 3 Comparison between AGA, SGA and LGA neonates regarding maternal BMI, placental weight and apoptosis and vitamin C
levels.
SGA (n = 10)
Mean ± SD
AGA (n = 42)
Mean ± SD
LGA (n = 8)
Mean ± SD




Maternal BMI (kg/m2) 32.96 ± 5.0 33.54 ± 4.92 38.63 ± 2.82 SGA AGA 0.58 0.739
LGA 5.67 0.011
AGA SGA 0.58 0.739
LGA 5.09 0.007
LGA SGA 5.67 0.011
AGA 5.09 0.007
Placental weight (gm) 541.61 ± 37.60 621.57 ± 56.06 720.33 ± 39.31 SGA AGA 79.96 0.000
LGA 178.72 0.000
AGA SGA 79.96 0.000
LGA 98.76 0.000
LGA SGA 178.72 0.000
AGA 98.76 0.000
Placental apoptotic index 0.38 ± 0.13 0.22 ± 0.15 0.21 ± 0.13 SGA AGA 0.16 0.003
LGA 0.17 0.000
AGA SGA 0.16 0.003
LGA 0.01 0.861
LGA SGA 0.17 0.000
AGA 0.01 0.861
Maternal plasma vitamin C (mg/l) 4.85 ± 0.50 7.3 ± 2.61 9.08 ± 1.77 SGA AGA 2.45 0.005
LGA 4.23 0.000
AGA SGA 2.45 0.005
LGA 1.78 0.012
LGA SGA 4.23 0.000
AGA 1.78 0.012
Neonatal plasma vitamin C (mg/l) 8.90 ± 0.71 13.56 ± 3.51 15.31 ± 2.81 SGA AGA 4.66 0.004
LGA 6.41 0.001
AGA SGA 4.66 0.004
LGA 1.75 0.190
LGA SGA 6.41 0.001
AGA 1.75 0.190
SGA= small for gestational age. AGA=Appropriate for gestational age. LGA= Large for gestational age. GA= Gestational age.
BMI: body mass index.
* Bonferroni.
Maternal–cord blood vitamin C status 85countries are SGA,18 compared with 23 percent of term infants
in developing countries.19 Moreover, a recent study showed
that 26.8% of males and 22.4% of females were born term
but SGA in low- and middle-income countries.20
Comparison between AGA, LGA and SGA neonates of
our study revealed signiﬁcant higher values of both maternal
and neonatal vitamin C in LGA compared to SGA and in
AGA compared to SGA. The effect of vitamin C on neonatal
anthropometry was further highlighted by ﬁnding positive sig-
niﬁcant correlations between maternal vitamin C level and all
neonatal anthropometry as well as placental weight and nega-
tive correlation with placental apoptotic index. Similarly, Jain
et al. found a signiﬁcant positive relationship between newborn
birth weight and maternal plasma vitamin C levels in addition
to signiﬁcant positive relationship between newborn birth
weights and newborn vitamin C levels.17 Another study found
that maternal serum vitamin C levels during the second trimes-
ter were positively correlated with birth weight and length in
full-term babies. They thought that there was probably not a
large change in vitamin C levels between the second trimester
and the term, because it might not be reasonable to believe that
lifestyle, such as dietary pattern, changes profoundly during
pregnancy.5 In contrast, Wang et al. studied the effect ofmaternal antioxidant vitamins on birth weight and found a
positive signiﬁcant effect of vitamin A but not E and C.15
Likewise, the current study showed a signiﬁcant positive
inﬂuence of maternal vitamin C level on placental weight
and a signiﬁcant negative inﬂuence on placental apoptotic
index. Similarly, a previous study showed a signiﬁcant lower
trophoblast expression for the endothelial scavenger receptor
low-density lipoproteinreceptor-1 (LOX-1) and the apoptotic
index in normal full-term pregnancy in women with higher lev-
els of prenatal vitamin C7, also, Hung et al. concluded that
concomitant administration of 50 mM of vitamins C and E
was observed to reduce apoptotic and autophagic changes in
the trophoblast layer of placenta at normoxia.21
Placental apoptosis is likely to be the underlying patho-
physiological mechanism affecting fetal growth. Our study
showed negative signiﬁcant correlations between placental
apoptotic index and neonatal weight, BMI as well as placental
weight. Moreover, placental weight was the most sensitive pre-
dictor of neonatal weight by multiple regression analysis fol-
lowed by maternal vitamin C. Similarly, a recent study
reported that placental weight is an important determinant
of both birth weight and fetal growth.22 Another study
reported that apoptosis is an essential feature of normal
86 A.M. Hegazy et al.placental development but is exaggerated in association with
placental disease, they stated that widespread apoptosis of
the syncytiotrophoblast may impair trophoblast function lead-
ing to the reduction in nutrient transport seen in IUGR.23
In the current study, maternal BMI positively inﬂuenced
neonatal weight and BMI. This corroborates with other stud-
ies that found a progressive increase in the mean infant birth
weight with increased maternal BMI. They stated that
increased BMI predisposes to development of gestational
hypertension and infant macrosomia. Also, the tendency for
an individual to give birth to a macrocosmic infant may sug-
gest a genetic element; while mothers with low BMI had babies
with the lowest birth weight in their population.24,25,1
In this work, maternal age had no signiﬁcant correlation
with neonatal anthropometry, placental weight and apoptosis
or vitamin C levels of mothers and babies. This was in agree-
ment with Acharya et al. who concluded that maternal age had
no signiﬁcant association with IUGR.26 Also Hayward et al.
found no differences in placental weight between adult and
teenage pregnancies.27 Other studies showed conﬂicting results
with a positive association between increasing maternal age
and increasing risk for IUGR28 while, another study revealed
that placentas from older mothers had a lower incidence of
apoptosis compared with those from younger mothers.29
Regarding the relation between maternal age and vitamin C
levels, similar to our results Kiondo et al. found no association
between maternal age and vitamin C levels.30
Conclusion
Maternal vitamin C level has a signiﬁcant positive impact on
neonatal anthropometry and placental weight while negatively
correlating with placental apoptosis. This denotes an impor-
tant role of vitamin C during pregnancy. Further longitudinal
studies, preferably randomized controlled trials to evaluate dif-
ferent effects of vitamin C supplementation during pregnancy
are warranted.
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